Recommendations alone will not avert a liver disease epidemic
The Federal Government needs to list new hepatitis C medicines on the Pharmaceutical Benefits Scheme (PBS) without further delay, according to the peak body representing the interests of a quarter of a million Australians living with the liver-destroying virus.
Responding to the latest round of Pharmaceutical Benefits Advisory Committee (PBAC) recommendations, Hepatitis Australia CEO Helen Tyrrell said a total of four* groundbreaking curative hepatitis C therapies have now received the green light for inclusion on the PBS but so far no listing date has been confirmed.
“It is a completely unacceptable situation. Recommendations alone will not cure anyone. It’s time to act on the advice of the experts and add these medicines to the PBS,” Ms Tyrrell said.
Importing Medicines and the Possible Risks.
Hepatitis Australia is aware some people have purchased, or are looking to import medicines from overseas for the treatment of hepatitis C. Hepatitis Australia advises caution and recommends you consider the information provided in our new factsheet 'Importing Medicines into Australia' carefully. You can download a copy or read the information online.
Hepatitis C Treatment Webcast - Now online!
If you missed our webcast on the 30th July it is now available to view online. The webcast, presented by Kevin Marriott and Prof. Greg Dore, provides the latest information about new treatments for hepatitis C and where we are up to with access to these medicines in Australia.
World Hepatitis Day and it's #TimeForAction
"I am so busy worrying about dying that I've actually forgotten that I need to live," Jane Kibble
On 28th July, World Hepatitis Day, an urgent call for government action to better equip half a million Australians living with viral hepatitis in combating life-threatening liver disease was issued by peak health groups.
Calling for increased testing, improved access to liver check-ups and rapid access to new therapies, Hepatitis Australia and the leading state and territory hepatitis organisations warn that 1,000 Australian lives are lost each year due to hepatitis-related liver disease, and without urgent action, deaths from viral hepatitis will increase.
Speaking on World Hepatitis Day (WHD), Hepatitis Australia CEO, Helen Tyrrell said that Australia must never lose sight of the fact that hepatitis B and C are preventable, treatable liver health conditions.
The Silent Disease - Inquiry into Hepatitis C in Australia
The House of Representatives Standing Committee on Health has tabled its final report following a Parliamentary Inquiry which commenced late 2014. Hepatitis Australia thanks the Committee for their comprehensive report, which included input from more than one hundred submissions and five public hearings allowing many people to make their voice heard.
Hepatitis C Treatment Update
We have just updated our fact sheet covering all you need to know about current treatments for hepatitis C and what is happening regarding new treatments. Check it out now and download a copy.
If you would like to see what Hepatitis Australia has been doing to highlight the need for access to the new treatments you can find out here.
Prison-based needle & syringe program doomed without government leadership.
1 April 2015 - The ACT Government is being urged to show political leadership and retain control over the introduction of a needle syringe program (NSP) at the Alexander Maconochie Centre – ACT Prison as a means to prevent the spread of blood borne viruses.
Hepatitis Australia and Hepatitis ACT are urging Corrections Minister Shane Rattenbury not to allow the Community and Public Sector Union the right to veto the introduction of the planned needle syringe program, saying this would “spell the death knell for good public health policy”.
You can also donate directly to Hepatitis Australia. Please contribute to our aim of a world without viral hepatitis by making a tax deductible donation. Find out more
Hepatitis Australia is a non-government, not-for-profit organisation that became incorporated in 1997. We do not provide services to individuals. To locate hepatitis services in your area visit the services page or call the Info line on 1300 437 222. Our members consist of the state and territory hepatitis organisations and other key services providing hepatitis services.
Page Updated: 29 June 2015